Cheng Hu

Mr. Cheng Hu

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
CHCheng Hu
Cheng Hu
Background. Perivascular hydrogel wrapping combines circumferential mechanical reinforcement with sustained local release of therapeutic payloads and is an emerging preclinical strategy for abdominal aortic aneurysm (AAA). Because no hydrogel-intervention transcriptome is publicly available, the molecular payloads best suited to extra-adventitial delivery remain undefined. This study used human AAA transcriptomes to prioritize secreted molecules that could be loaded into a perivascular hydrogel. Methods. Differential expression was performed with limma on human AAA datasets (GSE57691, with small and large AAA; GSE7084, AAA wall; GSE47472, AAA neck), and the differentially expressed genes (DEGs) were intersected with the Human Protein Atlas predicted secreted-protein set (1,902 genes). Candidates were examined by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment, STRING protein-protein interaction, single-sample gene-set enrichment analysis with immune correlations, single-cell localization (GSE166676), and cross-species comparison with mouse AAA (GSE12591). Results. The AAA molecular program was already established in small AAA, with no significant additional transcriptomic change between small and large lesions. Intersecting the DEGs with the secretome yielded 82 candidate secreted proteins (16 up-regulated and 66 down-regulated in small AAA). Up-regulated drivers (IL1B, IL6, TNF, CCL3L1, CXCL1, CXCL5) correlated with M1 macrophages, NLRP3, and MMP9, whereas down-regulated protective factors (FRZB, TIMP4, SPARCL1, SMOC2, IGFBP5, GPX3) localized to vascular smooth muscle cells and fibroblasts. NELL2 was the only novel secreted protein robustly up-regulated across datasets. Cross-species agreement with the angiotensin II mouse model was poor. Conclusions. This computational study identifies a tiered list of secreted molecules potentially suitable for perivascular hydrogel-cell delivery against AAA: inflammatory drivers to antagonize, lost protective factors to replenish, and novel targets such as NELL2 to validate. The mechanical supportive effect of hydrogels cannot be assessed by transcriptomics, and the candidates require biomaterial, animal, and safety experiments.

30 September 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
CHCheng Hu
Cheng Hu
Background: Dietary risk factors—high-fat, high-salt, high-sugar intake, chronic alcohol use, sugared carbonated beverages, and irregular eating—are epidemiologically associated with abdominal aortic aneurysm (AAA), but whether and through which molecular programs they converge on the aortic wall is poorly defined. No human aortic transcriptome with controlled dietary exposure exists in public repositories, which precludes direct case–control dietary differential-expression analysis in human tissue. Methods: We constructed six dietary-risk gene sets from animal-intervention transcriptomic studies in GEO, curated disease–gene association databases, and targeted literature mining. Human AAA differentially expressed genes (DEGs) were derived from GSE57691 (49 AAA vs. 10 non-aneurysmal donors) and GSE47472 (14 AAA vs. 8 donors) using limma (adjusted P<0.05, |log2FC|≥0.5); genes concordantly DE in both cohorts were retained as the consensus AAA set. Each dietary set was intersected with AAA DEGs; genes hit by ≥3 of six exposures were termed the strict core and genes hit by ≥2 were termed the extended core. Functional enrichment (GO/KEGG), STRING PPI analysis, and marker-based single-sample gene-set enrichment analysis (ssGSEA, GSVA) were performed. A per-sample multi-dietary score (DietScore) was computed in GSE57691 and its association with AAA status, the NLRP3–CASP1–IL1β–MMP9 axis, and marker-based immune signatures was tested by Wilcoxon and Spearman methods. Results: Thirty-six genes were shared between the six dietary sets and AAA DEGs. Seven strict-core genes were hit by ≥3 dietary exposures—IL1B (5 sets), NLRP3 (4), MMP9 (4), and IL6, CCL2, VCAM1, CAT (3 each)—and a further seven (CASP1, NFKB1, EDN1, NCF1, APOB, PPARG, MYH11) were hit by two. Enrichment converged on Lipid and atherosclerosis (P≈3×10⁻¹⁴), AGE–RAGE signaling in diabetic complications, NOD-like receptor (NLRP) signaling, and macrophage/foam-cell differentiation. STRING PPI centered on the NLRP3–CASP1–IL1β–IL6–MMP9 module. DietScore was higher in AAA than donor aorta (Wilcoxon P≈1.6×10⁻⁵) and correlated positively with CASP1 (ρ=0.59), IL1B (ρ=0.57), NLRP3 (ρ=0.47), MMP9 (ρ=0.46), and with macrophage, T-cell, and neutrophil signatures. Conclusions: This computational, hypothesis-generating integration of mostly animal-derived dietary gene sets with the human AAA transcriptome identifies a shared myeloid–inflammatory, NLRP3–IL1β–MMP9 program that is active in human AAA. The DietScore is an internally derived, descriptive computational index; it is not validated as a clinical AAA biomarker and must not be used for patient classification or diagnosis. This work does not establish a causal diet–AAA relationship; it cannot distinguish direct aortic-wall effects from effects mediated through hypertension, dyslipidemia, or diabetes; and the DietScore was derived and evaluated within a single cohort without an independently phenotyped external validation set. All findings require confirmation in dietary-intervention animal models and human AAA cohorts with matched dietary phenotypes.

23 September 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
CHCheng Hu
Cheng Hu
No drug has yet been shown to stop an aortic aneurysm (AA, abdominal AAA or thoracic TAA) from enlarging, and many patients are recognised only once the wall is already failing. Alongside the classical risk factors, three conditions that patients and clinicians can actually change—chronic cold exposure, lack of exercise and severe infection—have each been tied to faster progression, although their molecular overlap is rarely discussed together. This narrative review draws on 80 sources from PubMed, Web of Science and CNKI (2003–2026). Upstream the three insults look quite different: cold acts through extracellular cold-inducible RNA-binding protein (eCIRP)–TLR4 signalling and the sympathetic nervous system, inactivity through low and oscillatory wall shear stress, and infection through pathogen-associated molecular patterns. Downstream they meet on NF-κB, MMP-2/9, oxidative stress and loss of vascular smooth muscle cells, with the NLRP3 inflammasome as the shared bottleneck—its caspase-1 both releases IL-1β/IL-18 and cleaves pro-MMP-9 directly. We use this convergence to re-read the still piecemeal single-omics evidence and weigh NLRP3-, IL-1β- and CIRP-directed drugs against exercise, warmth and vaccination. The clearest gaps are multifactorial models, paired multi-omics cohorts and trials that follow expansion rate.

21 September 2026 in Research Square
Verified
Preprint
Open access
PDF file
CHCheng Hu
Cheng Hu
Background Abdominal aortic aneurysm (AAA) is a life-threatening cardiovascular disease marked by progressive aortic dilation and a high risk of rupture. No reliable circulating biomarker currently exists for early detection, and the molecular events driving AAA remain only partly understood. Cellular senescence is a state of irreversible cell-cycle arrest coupled to a pro-inflammatory senescence-associated secretory phenotype (SASP). It has been linked to vascular aging and aneurysm formation, yet a systematic transcriptomic survey of senescence-related genes in AAA has not been reported. Methods Three GEO datasets were used: GSE57691 (49 AAA vs. 10 control) as the training cohort, GSE47472 (14 AAA vs. 8 control) as the external validation cohort with matched controls, and GSE98278 (48 AAA samples without controls) as an independent AAA cohort for exploratory subtype analysis. Differentially expressed genes (DEGs) were identified with the limma package. Senescence-related DEGs (SRDEGs) were obtained by intersecting the DEG list with a 167-gene cellular senescence signature compiled from the CellAge database and published reviews. Functional enrichment (GO, KEGG, GSEA), a protein-protein interaction (PPI) network with an expanded first-order-neighbor extension, and three machine learning algorithms (LASSO, SVM-RFE, random forest) were applied to the six SRDEGs to isolate hub genes. Immune infiltration was estimated by single-sample gene set enrichment analysis (ssGSEA). A two-gene nomogram was built and validated externally in GSE47472. Results Six SRDEGs were recovered: FOXO1, MAP1LC3B, SOD1, IGFBP3 (all downregulated), and IL1B, IL6 (both upregulated). Enrichment pointed to apoptotic regulation, interleukin-1-mediated signaling, insulin secretion, the AGE-RAGE pathway, and cellular senescence. Intersecting three machine learning

20 October 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
CHCheng Hu
Cheng Hu
Background. Perivascular hydrogel wrapping of abdominal aortic aneurysm (AAA) can sustain high local drug concentrations while avoiding systemic exposure, but no study has systematically prioritized which approved small molecules are best suited to such an extra-adventitial depot. This study combined drug-target evidence with physicochemical filtering to rank small-molecule candidates for local hydrogel formulation. Methods. Differentially expressed AAA genes were integrated from public human datasets (GSE57691, GSE7084, GSE47472) and mapped to approved small molecules using the Open Targets platform and ChEMBL. Links were filtered for coherent direction (inhibitors targeting up-regulated genes), and retained drugs were profiled with RDKit for molecular weight, lipophilicity (logP), and topological polar surface area (TPSA). A local-fit rule (molecular weight 200-500, logP 1-4, TPSA below 150) was applied, and candidates were organized into three tiers. Results. The integrated AAA target set contained 2,437 genes. Matching to approved small molecules yielded 1,061 drug-target links, and coherent filtering retained 152 links (121 drugs, 32 targets). The leading Tier 1 candidates were sulfasalazine, dasatinib, and celecoxib, targeting ALOX5/PTGS2 and the Src-family kinases. A second tier included diclofenac, etoricoxib, zileuton, balsalazide, idelalisib, ibuprofen, and ketorolac. The literature anchors colchicine (suitable physicochemistry) and doxycycline (borderline, overly hydrophilic) were retained separately, and the central AAA targets matrix metalloproteinase (MMP)-9, MMP-12, NLRP3, and CASP1 had no approved small-molecule ligand. Conclusions. This computational analysis prioritizes a small set of approved, physicochemically suitable small molecules for local perivascular hydrogel delivery against AAA. The ranking is a formulation hypothesis rather than evidence of efficacy; local release, toxicity, and in vivo effects require biomaterial and animal validation.